相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice
Mark J. Benvenga et al.
FRONTIERS IN PHARMACOLOGY (2018)
Phase-plate cryo-EM structure of a class B GPCR-G-protein complex
Yi-Lynn Liang et al.
NATURE (2017)
Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects
Daisuke Ibi et al.
NATURE NEUROSCIENCE (2017)
Drug Abuse and Psychosis: New Insights into Drug- induced Psychosis
Suji Ham et al.
EXPERIMENTAL NEUROBIOLOGY (2017)
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation
Katrin H. Preller et al.
CURRENT BIOLOGY (2017)
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
Alex R. B. Thomsen et al.
CELL (2016)
Issues related to sex differences in antipsychotic treatment
Mitchell B. Crawford et al.
CURRENT OPINION IN PSYCHIATRY (2016)
Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells
Lia Baki et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Jose L. Moreno et al.
SCIENCE SIGNALING (2016)
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Jose L. Moreno et al.
SCIENCE SIGNALING (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Atypical Antipsychotics and Inverse Agonism at 5-HT2 Receptors
Laura C. Sullivan et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Preclinical evaluation of the antipsychotic potential of the mGlu2-positive allosteric modulator JNJ-40411813
Hilde lavreysen et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Drug models of schizophrenia
Hannah Steeds et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2015)
Family a GPCR heteromers in animal models
Javier Gonzalez-Maeso
FRONTIERS IN PHARMACOLOGY (2014)
G Protein-Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferre et al.
PHARMACOLOGICAL REVIEWS (2014)
Animal Models of Serotonergic Psychedelics
James B. Hanks et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Update on Typical and Atypical Antipsychotic Drugs
Herbert Y. Meltzer
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice
Jose L. Moreno et al.
PSYCHOPHARMACOLOGY (2013)
Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice
J. W. Young et al.
TRANSLATIONAL PSYCHIATRY (2013)
Functional Selectivity in Serotonin Receptor 2A (5-HT2A) Endocytosis, Recycling, and Phosphorylation
Ishier Raote et al.
MOLECULAR PHARMACOLOGY (2013)
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
Jorgen G. Bramness et al.
BMC PSYCHIATRY (2012)
Identification of Three Residues Essential for 5-Hydroxytryptamine 2A-Metabotropic Glutamate 2 (5-HT2A.mGlu2) Receptor Heteromerization and Its Psychoactive Behavioral Function
Jose L. Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S. Miyamoto et al.
MOLECULAR PSYCHIATRY (2012)
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Mitsumasa Kurita et al.
NATURE NEUROSCIENCE (2012)
Clozapine-Induced Locomotor Suppression is Mediated by 5-HT2A Receptors in the Forebrain
Caitlin E. McOmish et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Animal Models of Neuropsychiatric Disorders
A. B. P. Fernando et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY (2011)
Animal models of schizophrenia
C. A. Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs
Miguel Fribourg et al.
CELL (2011)
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
Jose L. Moreno et al.
NEUROSCIENCE LETTERS (2011)
GPCR oligomers in pharmacology and signaling
Javier Gonzalez-Maeso
MOLECULAR BRAIN (2011)
Antagonist Functional Selectivity: 5-HT2A Serotonin Receptor Antagonists Differentially Regulate 5-HT2A Receptor Protein Level In Vivo
Prem N. Yadav et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Interaction of 5-HT2A and 5-HT2C Receptors in R(-)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice
W. E. Fantegrossi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics
Andrea M. Bradford et al.
PSYCHOPHARMACOLOGY (2010)
Purification and Functional Reconstitution of Monomeric μ-Opioid Receptors ALLOSTERIC MODULATION OF AGONIST BINDING BY Gi2
Adam J. Kuszak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice
Adam L. Halberstadt et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection
Jeffrey A. Lieberman et al.
PHARMACOLOGICAL REVIEWS (2008)
Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer
Matthew R. Whorton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity
M. L. Woolley et al.
PSYCHOPHARMACOLOGY (2008)
The amphetamine-induced sensitized state as a model of schizophrenia
R. E. Featherstone et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
Matthew R. Whorton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Modeling madness in mice: One piece at a time
P. Alexander Arguello et al.
NEURON (2006)
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice
Noelia V. Weisstaub et al.
SCIENCE (2006)
Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice
Y Morishima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Delayed-onset hypothesis of antipsychotic action - A hypothesis tested and rejected
O Agid et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
D Umbricht et al.
BIOLOGICAL PSYCHIATRY (2002)
The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis
A Bhatnagar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers -: Implications for models of cognitive deficits in schizophrenia
D Umbricht et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
分享论文
